Back to search

Article

Salidroside inhibits platelet-derived growth factor BB-induced human aortic smooth muscle cell phenotype switching via PDGFR-β/AKT/mTOR/HIF-1α pathway 1

2024-01-09

Abstract excerpt

Vascular smooth muscle cell (VSMC) phenotype transformation is the pathological basis of vascular remodeling diseases such as in-stent restenosis after percutaneous coronary intervention. Salidroside has anti-hypoxic and anti-endothelial cell apoptotic effects and inhibits tumor cell proliferation; however, none of the published studies have reported its effect on VSMC phenotype switching to date. In this study, w...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
95917283-69b2-526a-b778-05e2d3567b1a
DOI
10.21203/rs.3.rs-3841194/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Salidroside inhibits platelet-derived growth factor BB-induced human aortic smooth muscle cell phenotype switching via PDGFR-β/AKT/mTOR/HIF-1α pathway 1DOI 10.21203/rs.3.rs-3841194/v1
[Mechanism of salidroside in inhibiting proliferation, migration and promoting phenotypic switching of arterial smooth muscle cells].Semantic proximity
A newly synthesized Ligustrazine stilbene derivative inhibits PDGF-BB induced vascular smooth muscle cell phenotypic switch and proliferation via delaying cell cycle progression.Semantic proximity
Crocin prevents platelet‑derived growth factor BB‑induced vascular smooth muscle cells proliferation and phenotypic switch.Semantic proximity
Lycorine hydrochloride reveals a novel role in preventing neointimal hyperplasia through MAPK-mediated phenotypic switching of smooth muscle cells.Semantic proximity
Vascular Smooth Muscle Cells Phenotypic Switching in Cardiovascular Diseases.Semantic proximity
Ulinastatin Inhibits the Proliferation, Invasion and Phenotypic Switching of PDGF-BB-Induced VSMCs via Akt/eNOS/NO/cGMP Signaling Pathway.Semantic proximity
N-Butylidenephthalide Inhibits the Phenotypic Switch of VSMCs through Activation of AMPK and Prevents Stenosis in an Arteriovenous Fistula Rat Model.Semantic proximity
Regulation of autophagy by controlling Erk1/2 and mTOR for platelet-derived growth factor-BB-mediated vascular smooth muscle cell phenotype shift.Semantic proximity
miR-34c inhibits PDGF-BB-induced HAVSMCs phenotypic transformation and proliferation via PDGFR-β/SIRT1 pathway.Semantic proximity
Metformin inhibits intracranial aneurysm formation and progression by regulating vascular smooth muscle cell phenotype switching via the AMPK/ACC pathway.Semantic proximity
miR-200a-3p inhibits the PDGF-BB-induced proliferation of VSMCs by affecting their phenotype-associated proteins.Semantic proximity
7-O-methylpunctatin, a Novel Homoisoflavonoid, Inhibits Phenotypic Switch of Human Arteriolar Smooth Muscle Cells.Semantic proximity
Select a neighboring publication to make it the new centre.